More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F17%3A10362320" target="_blank" >RIV/00064165:_____/17:10362320 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.ejca.2017.01.012" target="_blank" >http://dx.doi.org/10.1016/j.ejca.2017.01.012</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejca.2017.01.012" target="_blank" >10.1016/j.ejca.2017.01.012</a>
Alternative languages
Result language
angličtina
Original language name
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
Original language description
Background: Despite the efficacy of innovative treatments for metastatic melanoma, their high costs has led to disparities in cancer care among different European countries. We analysed the availability of these innovative therapies in Europe and estimated the number of patients without access to first-line recommended treatment per current guidelines of professional entities such as the European Society for Medical Oncology (ESMO), the European Organisation for Research and Treatment of Cancer (EORTC), the European Association of Dermato-Oncology (EADO), and European Dermatology Forum (EDF). Materials and methods: Web-based online survey was conducted in 30 European countries with questions about the treatment schedules from 1st May 2015 to 1st May 2016: number of metastatic melanoma patients, registration and reimbursement of innovative medicines (updated data, as of 1st October 2016), percentage of patients treated and availability of clinical studies and compassionate-use programmes.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Journal of Cancer
ISSN
0959-8049
e-ISSN
—
Volume of the periodical
75
Issue of the periodical within the volume
April
Country of publishing house
GB - UNITED KINGDOM
Number of pages
10
Pages from-to
313-322
UT code for WoS article
000399856400040
EID of the result in the Scopus database
2-s2.0-85014383793